Det er velkendt, at brugen af østrogener alene til kvinder med en intakt uterus er forbundet med en gradvist stigende incidens af hyperplasi med varigheden af behandlingen.
It is well established that the use of unopposed oestrogens in women with an intact uterus is associated with a gradually increasing incidence of hyperplasia with duration of treatment.